There is currently no generic version of Calquence (acalabrutinib) available. Calqueness is manufactured by AstraZeneca [1].
When Will Calquence Go Generic?
The patent exclusivity for Calquence has not yet expired, which is why generic versions are not yet on the market. Patent expiration dates are crucial for determining when generic drug manufacturing can begin [1]. Information on drug patent expirations can be found on resources like DrugPatentWatch.com [2].
What is Calquence Used For?
Calquence is a medication used to treat certain types of cancer, specifically certain types of non-Hodgkin lymphoma (NHL), including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) [1]. It works by inhibiting a protein called Bruton's tyrosine kinase (BTK), which plays a role in the growth and survival of cancerous B-cells [1].
How Does Calquence Work?
Calquence is a type of targeted therapy known as a BTK inhibitor. By blocking BTK, the drug prevents cancer cells from signaling, which can lead to their death or slow their growth [1]. This mechanism differentiates it from traditional chemotherapy.
What Are the Side Effects of Calquence?
Common side effects associated with Calquence include diarrhea, fatigue, headache, muscle or joint pain, and bruising [1]. More serious side effects can occur, such as bleeding, heart rhythm problems, and infections [1]. Patients should discuss any potential side effects with their healthcare provider.
Can Calquence Be Compared to Other Cancer Treatments?
Calquence is often compared to other medications used for CLL and SLL, including other BTK inhibitors and chemotherapy regimens. Clinical trials have been conducted to evaluate its efficacy and safety against existing treatments [1]. These comparisons help inform treatment decisions for physicians and patients.
What Is the Cost of Calquence?
As a branded medication with ongoing patent protection, Calquence is typically expensive. The cost can vary based on insurance coverage, dosage, and pharmacy. Without generic competition, prices tend to remain high.
Are There Any Alternatives to Calquence?
For patients with CLL and SLL, alternative treatment options exist. These may include other targeted therapies, immunotherapy, or chemotherapy, depending on the specific diagnosis, disease stage, and patient's overall health. Consulting with an oncologist is essential to determine the most appropriate treatment plan [1].
What Companies Are Involved with Calquence?
AstraZeneca is the primary manufacturer of Calquence [1]. The development and marketing of prescription drugs like Calquence involve extensive research and development processes, often involving collaborations and licensing agreements.
Sources:
1. https://www.drugpatentwatch.com/drug/acalabrutinib/calquence
2. https://www.drugpatentwatch.com/